Biomaterials in Spinal Implants: A Review

by Andrew Warburton, Steven J. Girdler, Christopher M. Mikhail, Amy Ahn, Samuel K. Cho
Published 2020-03-01

Leveraging NADAC to Steer Drug Formularies in Resource-Limited Clinics

by Andrew Warburton, Randal Serafini, Benjamin Shuham, Andrew Leader, Sharon Barazani, Joe-Ann Moser, Yasmin Meah
Published 2019-08-01

Determining the Factors Associated With 30- and 90-day Readmissions Following Plastic Surgery Within the National Readmissions Database

by Farah Sayegh, MD, Andrew Warburton, BS, Paymon Sanati-Mehrizy, MD, Nikki M. Burish, MD, Peter J. Taub, MD
Published 2020-09-01